Yul Hee Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yul Hee Kim has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Eun-So Lee
Department of Dermatology, Ajou University School of Medicine, Suwon, Republic of Korea
2 shared publications - Jee Woong Choi
Department of Dermatology Ajou University School of Medicine Suwon Korea
2 shared publications - Jin Park
Department of Dermatology, College of Medicine, Jeonbuk National University, Jeonju, Korea
2 shared publications - You Chan Kim
Department of Dermatology Ajou University School of Medicine Suwon Korea
2 shared publications - Young Joon Park
Department of Dermatology, Ajou University School of Medicine, Suwon, Korea
2 shared publications - Bark-Lynn Lew
Department of Dermatology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- 21 February 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (9) , e772-e774
Associations between the tissue bacterial microbiome and keratinocyte cancer
- 21 February 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (9) , e772-e774
Associations between the tissue bacterial microbiome and keratinocyte cancer
- 23 August 2023
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 39 (6) , 613-619
A novel treatment for Riehl's melanosis targeting both dermal melanin and vessels
Background/purpose: Riehl's melanosis is a difficult‐to‐treat condition characterized by persisting dermal hyperpigmentation. This study aimed to evaluate the efficacy of a histology‐specific targeted therapy for Riehl's melanosis.Methods: Skin biopsy samples of Riehl's melanosis were assessed to identify histology‐specific targets for treatment. Subsequently, the efficacy of a combination involving a fractional picosecond laser and a pulsed dye laser (PDL) targeting the dermal melanin and vessels, respectively, was evaluated. Clinical improvement was assessed using the dermal pigmentation area and severity index (DPASI). The treatment outcomes were compared to those of a control, in this case a single laser treatment solely targeting pigmentation.Results: Histological and immunohistochemical analyses identified dermal melanin pigment and dilated vessels as treatment targets for Riehl's melanosis. The combined treatment of the fractional picosecond laser and PDL showed a significant reduction of the DPASI scores, which was significantly better than the control group. Patients who underwent the combined laser treatment indicated high levels of satisfaction with no adverse events except of transient erythema and oedema.Conclusion: The combined treatment of a fractional picosecond laser and a PDL was more effective for Riehl's melanosis compared to single laser treatment. The treatment targets both dermal pigmentation and dilated vessels, offering promising results for those working to manage Riehl's melanosis.
- 23 August 2023
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 39 (6) , 613-619
A novel treatment for Riehl's melanosis targeting both dermal melanin and vessels
Background/purpose: Riehl's melanosis is a difficult‐to‐treat condition characterized by persisting dermal hyperpigmentation. This study aimed to evaluate the efficacy of a histology‐specific targeted therapy for Riehl's melanosis.Methods: Skin biopsy samples of Riehl's melanosis were assessed to identify histology‐specific targets for treatment. Subsequently, the efficacy of a combination involving a fractional picosecond laser and a pulsed dye laser (PDL) targeting the dermal melanin and vessels, respectively, was evaluated. Clinical improvement was assessed using the dermal pigmentation area and severity index (DPASI). The treatment outcomes were compared to those of a control, in this case a single laser treatment solely targeting pigmentation.Results: Histological and immunohistochemical analyses identified dermal melanin pigment and dilated vessels as treatment targets for Riehl's melanosis. The combined treatment of the fractional picosecond laser and PDL showed a significant reduction of the DPASI scores, which was significantly better than the control group. Patients who underwent the combined laser treatment indicated high levels of satisfaction with no adverse events except of transient erythema and oedema.Conclusion: The combined treatment of a fractional picosecond laser and a PDL was more effective for Riehl's melanosis compared to single laser treatment. The treatment targets both dermal pigmentation and dilated vessels, offering promising results for those working to manage Riehl's melanosis.
- 22 May 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (7) , 895-899
Epidemiology and survival analysis of Merkel cell carcinoma in South Korea: a nationwide, multicenter retrospective study
Background: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer, of which most research has been conducted in Caucasians. Therefore, the clinicopathological features and prognosis of Merkel cell carcinoma in Asians are still scarce. The aim of this study is to investigate the epidemiology and survival of MCC in South Korea and provide representative information regarding MCC in Asia.Methods: This was a retrospective, nationwide, multicenter study conducted in 12 centers across South Korea. Patients with pathologically proven MCC were included in the study. The clinicopathological features and clinical outcomes of the patients were investigated. Overall survival (OS) was analyzed using the Kaplan–Meier method, and independent prognostic factors were identified using Cox regression analysis.Results: A total of 161 patients with MCC were evaluated. The mean age was 71 years with a female predominance. OS was significantly different among the stages. Among clinicopathological features, multivariate Cox regression analysis demonstrated that only the stage at diagnosis was associated with poorer overall survival.Conclusions: The results of our study suggest that the incidence of MCC was higher in females than in males and that there was a higher rate of local disease at the time of diagnosis. Among the variable clinicopathological features, disease stage at diagnosis was the only significant prognostic factor for MCC in South Korea. The findings of this nationwide, multicenter study suggest that MCC has distinct features in South Korea compared with other countries.
- 22 May 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (7) , 895-899
Epidemiology and survival analysis of Merkel cell carcinoma in South Korea: a nationwide, multicenter retrospective study
Background: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer, of which most research has been conducted in Caucasians. Therefore, the clinicopathological features and prognosis of Merkel cell carcinoma in Asians are still scarce. The aim of this study is to investigate the epidemiology and survival of MCC in South Korea and provide representative information regarding MCC in Asia.Methods: This was a retrospective, nationwide, multicenter study conducted in 12 centers across South Korea. Patients with pathologically proven MCC were included in the study. The clinicopathological features and clinical outcomes of the patients were investigated. Overall survival (OS) was analyzed using the Kaplan–Meier method, and independent prognostic factors were identified using Cox regression analysis.Results: A total of 161 patients with MCC were evaluated. The mean age was 71 years with a female predominance. OS was significantly different among the stages. Among clinicopathological features, multivariate Cox regression analysis demonstrated that only the stage at diagnosis was associated with poorer overall survival.Conclusions: The results of our study suggest that the incidence of MCC was higher in females than in males and that there was a higher rate of local disease at the time of diagnosis. Among the variable clinicopathological features, disease stage at diagnosis was the only significant prognostic factor for MCC in South Korea. The findings of this nationwide, multicenter study suggest that MCC has distinct features in South Korea compared with other countries.
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (2) , 132-139
Clinical Characteristics of Psoriasis for Initiation of Biologic Therapy: A Cluster Analysis
Kim YH, et al. Ann Dermatol. 2023 Mar;35:e18. https://doi.org/10.5021/ad.22.148
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (2) , 132-139
Open AccessClinical Characteristics of Psoriasis for Initiation of Biologic Therapy: A Cluster Analysis
Kim YH, et al. Ann Dermatol. 2023 Mar;35:e18. https://doi.org/10.5021/ad.22.148
- Open Access
- 22 July 2022
- Published by XMLink in Annals of Dermatology
- Vol. 34 (4) , 237-244
Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study
Choi JW, et al. Ann Dermatol. 2022 Aug;34(4):237-244. https://doi.org/10.5021/ad.21.202
- 22 July 2022
- Published by XMLink in Annals of Dermatology
- Vol. 34 (4) , 237-244
Open AccessImpact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study
Choi JW, et al. Ann Dermatol. 2022 Aug;34(4):237-244. https://doi.org/10.5021/ad.21.202
- Open Access
- 25 May 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 905239
Comparative Analysis of Single-Cell Transcriptome Data Reveals a Novel Role of Keratinocyte-Derived IL-23 in Psoriasis
Psoriasis, a common inflammatory skin disease, is critically dependent on the IL-23/IL-17 cytokine axis. Although immune cell-derived IL-23 is generally associated with the disease pathogenesis, there have been reports of IL-23 production in keratinocytes. To determine the presence and potential role of keratinocyte-derived IL-23 in psoriasis, we investigated its expression levels using publicly available single-cell RNA sequencing data from human samples. We discovered that the expression of IL23A was detectable in keratinocytes as well as dendritic cells. Furthermore, we examined the IL-23p19 expression in an imiquimod-induced mouse model of psoriasis and found a close relationship between keratinocyte-produced IL-23 and IL-36, another key cytokine in psoriasis pathogenesis. The blockade of IL-23 signaling resulted in the reduced expression of IL-36 in the keratinocytes. Our findings reveal the novel association between keratinocyte-derived IL-23 and IL-36 in psoriasis progression.
- 25 May 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 905239
Open AccessComparative Analysis of Single-Cell Transcriptome Data Reveals a Novel Role of Keratinocyte-Derived IL-23 in Psoriasis
Psoriasis, a common inflammatory skin disease, is critically dependent on the IL-23/IL-17 cytokine axis. Although immune cell-derived IL-23 is generally associated with the disease pathogenesis, there have been reports of IL-23 production in keratinocytes. To determine the presence and potential role of keratinocyte-derived IL-23 in psoriasis, we investigated its expression levels using publicly available single-cell RNA sequencing data from human samples. We discovered that the expression of IL23A was detectable in keratinocytes as well as dendritic cells. Furthermore, we examined the IL-23p19 expression in an imiquimod-induced mouse model of psoriasis and found a close relationship between keratinocyte-produced IL-23 and IL-36, another key cytokine in psoriasis pathogenesis. The blockade of IL-23 signaling resulted in the reduced expression of IL-36 in the keratinocytes. Our findings reveal the novel association between keratinocyte-derived IL-23 and IL-36 in psoriasis progression.
- Open Access
- 11 January 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (5) , E328-E330
Wells’ syndrome following Oxford–AstraZeneca COVID‐19 vaccination
- 11 January 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (5) , E328-E330
Open AccessWells’ syndrome following Oxford–AstraZeneca COVID‐19 vaccination
- 13 November 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 186 (4) , 740-742
The potential skin‐lightening candidate, senolytic drug ABT263, for photoageing pigmentation
- 13 November 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 186 (4) , 740-742
The potential skin‐lightening candidate, senolytic drug ABT263, for photoageing pigmentation